Yanni Sun

TL;DR: This review summarized resveratrol's discovery, sources and isolation methods, administration methods, effects in different types of leukemia, pharmacokinetics and toxicities, aiming to exploit resver atrol as a potential drug candidate for anti-leukemia.

TL;DR: In this paper, the authors searched MEDLINE, Embase, and Cochrane Library for eligible randomized controlled trials (RCTs) that compared new anti-CD20 mAbs with rituximab in induction therapy of B-NHL.

TL;DR: In this article, the authors compared the efficacy of different HSC mobilization regimens and identified new promising regimens with a network meta-analysis of preclinical studies, and found that long-term SD G-CSF + Me6 significantly increased the collections of Lin− Sca1+ Kit+ (LSK) cells.

TL;DR: It is confirmed that high CD56 expression is associated with adverse clinical outcomes in de novo non-M3 AML patients, indicating that CD56 could be used as a prognostic marker for a more precise stratification of de noVO non- M3 AMl patients.

TL;DR: Findings indicated that PAD2 plays a role in ER homeostasis maintenance and apoptosis prevention, and targeting PAD 2 with BB-Cl-A could represent a novel therapeutic strategy for treating AML.